Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: A report from the north American malignant hyperthermia registry of the malignant hyperthermia association of the United States

Anesthesia and Analgesia

Volumn 119, Issue 6, 2014, Pages 1359-1366

  Larach, Marilyn Green ^a   Brandom, Barbara W ^a   Allen, Gregory C ^b   Gronert, Gerald A ^c   Lehman, Erik B ^d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Olympia Anesthesia Associates   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; DANTROLENE; RYANODINE RECEPTOR 1; CACNA1S PROTEIN, HUMAN; CALCIUM CHANNEL; RYANODINE RECEPTOR;

ADULT; AGED; ARTICLE; CORE TEMPERATURE; DEATH; DNA DETERMINATION; DYING; ELECTIVE SURGERY; FAMILY HISTORY; HEART ARREST; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT HYPERTHERMIA; MEDICAL HISTORY; MORTALITY; POSTANESTHESIA CARE; PREOPERATIVE PERIOD; RESUSCITATION; RISK FACTOR; SKIN TEMPERATURE; TEMPERATURE MEASUREMENT; ADOLESCENT; CANADA; CAUSE OF DEATH; EPIDEMIOLOGY; FEMALE; GENERAL ANESTHESIA; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY; PATIENT MONITORING; PREDICTIVE VALUE; REGISTER; RISK ASSESSMENT; THERMOMETRY; THERMOREGULATION; TIME; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANESTHESIA, GENERAL; BODY TEMPERATURE REGULATION; CALCIUM CHANNELS; CANADA; CAUSE OF DEATH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART ARREST; HUMANS; MALE; MALIGNANT HYPERTHERMIA; MIDDLE AGED; MONITORING, INTRAOPERATIVE; MUTATION; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; THERMOMETRY; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84914110185     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000421     Document Type: Article

References (17)

1. Brandom BW, Bina S, Wong CA, Wallace T, Visoiu M, Isackson PJ, Vladutiu GD, Sambuughin N, Muldoon SM. Ryanodine receptor type 1 gene variants in the malignant hyperthermiasusceptible population of the United States. Anesth Analg 2013;116:1078-86
2. Monnier N, Kozak-Ribbens G, Krivosic-Horber R, Nivoche Y, Qi D, Kraev N, Loke J, Sharma P, Tegazzin V, Figarella-Branger D, Roméro N, Mezin P, Bendahan D, Payen JF, Depret T, Maclennan DH, Lunardi J. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility. Hum Mutat 2005;26:413-25
3. Li G, Warner M, Lang BH, Huang L, Sun LS. Epidemiology of anesthesia-related mortality in the United States, 1999-2005. Anesthesiology 2009;110:759-65
4. Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB. Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: a report from The North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States. Anesthesiology 2008;108:603-11
5. Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg 2010;110:498-507
6. Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, Kaplan RF, Muldoon SM, Nelson TE, rding H, Rosenberg H, Waud BE, Wedel DJ. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994;80:771-9
7. Cochran WG. Some methods for strengthening the common chi-square tests. Biometrics 1954;10:417-51
8. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955;11:375-86
9. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med 1985;4:213-26
10. Bynum GD, Pandolf KB, Schuette WH, Goldman RF, Lees DE, Whang-Peng J, Atkinson ER, Bull JM. Induced hyperthermia in sedated humans and the concept of critical thermal maximum. Am J Physiol 1978;235:R228-36
11. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002;346:1978-88
12. Sessler DI. Temperature monitoring and perioperative thermoregulation. Anesthesiology 2008;109:318-38
13. Litman RS, Flood CD, Kaplan RF, Kim YL, Tobin JR. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry. Anesthesiology 2008;109:825-9
14. Girard T, Treves S, Voronkov E, Siegemund M, Urwyler A. Molecular genetic testing for malignant hyperthermia susceptibility. Anesthesiology 2004;100:1076-80
15. Brandom BW, Muldoon SM. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients. Paediatr Anaesth 2013;23:851-4
16. Urwyler A, Deufel T, McCarthy T, West S; for the European Malignant Hyperthermia Group. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 2001;86:283-7
17. Newmark JL, Voelkel M, Brandom BW, Wu J. Delayed onset of malignant hyperthermia without creatine kinase elevation in a geriatric, ryanodine receptor type 1 gene compound heterozygous patient. Anesthesiology 2007;107:350-3